208 related articles for article (PubMed ID: 28282388)
1. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.
Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW
PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388
[TBL] [Abstract][Full Text] [Related]
2. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
[TBL] [Abstract][Full Text] [Related]
3. Impact of D-dimer levels for short-term or long-term outcomes in cryptogenic stroke patients.
Nezu T; Kitano T; Kubo S; Uemura J; Yamashita S; Iwanaga T; Inoue T; Hosomi N; Maruyama H; Matsumoto M; Kimura K; Yagita Y
J Neurol; 2018 Mar; 265(3):628-636. PubMed ID: 29372390
[TBL] [Abstract][Full Text] [Related]
4. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival for patients with cancer after cryptogenic stroke.
Shin YW; Lee ST; Jung KH; Kim DY; Park CK; Kim TM; Choi SH; Chu K; Lee SK
J Neurooncol; 2016 Jun; 128(2):277-84. PubMed ID: 26968716
[TBL] [Abstract][Full Text] [Related]
6. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
[TBL] [Abstract][Full Text] [Related]
7. Plasma D-dimer level is associated with clinical outcomes in patients with atrial fibrillation related acute ischemic stroke after pneumonia.
Yang X; Lu T; Qu Z; Zhang Y; Liu P; Ma Y
BMC Neurol; 2021 Mar; 21(1):137. PubMed ID: 33773590
[TBL] [Abstract][Full Text] [Related]
8. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism.
Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Associated Hypercoagulation Increases the Risk of Early Recurrent Stroke in Patients with Active Cancer.
Fujinami J; Ohara T; Kitani-Morii F; Tomii Y; Makita N; Yamada T; Kasai T; Nagakane Y; Nakagawa M; Mizuno T
Cerebrovasc Dis; 2018; 46(1-2):46-51. PubMed ID: 30064137
[TBL] [Abstract][Full Text] [Related]
10. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients.
Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD
Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943
[TBL] [Abstract][Full Text] [Related]
11. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.
Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y
Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Di Napoli M; Papa F;
Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
[TBL] [Abstract][Full Text] [Related]
13. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern.
Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of early D-dimer level in patients with acute ischemic stroke.
Zhang J; Liu L; Tao J; Song Y; Fan Y; Gou M; Xu J
PLoS One; 2019; 14(2):e0211458. PubMed ID: 30707716
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study.
Guo YJ; Chang MH; Chen PL; Lee YS; Chang YC; Liao YC
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e249-54. PubMed ID: 24295603
[TBL] [Abstract][Full Text] [Related]
16. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
18. The Risk Factors for Death within 6 Months After Ischemic Stroke in Patients with Cancer.
Tsuchihashi Y; Shimizu T; Akiyama H; Hagiwara Y; Soga K; Takao N; Uchino K; Yanagisawa T; Yamauchi J; Sato T; Hasegawa Y; Yamano Y
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105365. PubMed ID: 33075707
[TBL] [Abstract][Full Text] [Related]
19. Clues to occult cancer in patients with ischemic stroke.
Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
[TBL] [Abstract][Full Text] [Related]
20. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Woodward M; Lowe GD; Campbell DJ; Colman S; Rumley A; Chalmers J; Neal BC; Patel A; Jenkins AJ; Kemp BE; MacMahon SW
Stroke; 2005 Oct; 36(10):2143-7. PubMed ID: 16151030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
